Edinburgh, United Kingdom · Founded 2017 · Privately Held (backing)
Developer of a dry powder inhaler designed to assist with inhalable medications. 1nhaler is based in Edinburgh, United Kingdom and was founded in 2017. Its last reported valuation was $13.8 million in Nov 2025. It has raised $4.5 million.
Last reported valuation
$13.8M
Oct 2026
Priced at
—
Total raised
$4.5M
Last round
—
How much has 1nhaler raised?
$4.5Macross 0 recorded rounds
Free account
More of 1nhaler with a free account
·Watch 1nhaler: the Monday email on marks, rounds and moves